News

Articles

April 22, 2019

BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats

Amylin analogs are important adjunctive drugs in the treatment of diabetes mellitus. However, a dual therapy with insulin involves inconvenient multiple injections. Here we describe a novel n-terminal PEGylated human amylin analog – BZ043 – and its potential to improve the control of glycemia using lower doses of insulin. The effect of BZ043 over the insulin-mediated control of fed-glycemia was investigated in rats with streptozotocin-induced diabetes treated with the basal analog glargine (GLAR). Fasted rats (3 h) received a single treatment of BZ043 (16, 64 or 128 nmol/kg), GLAR (1.5 IU or 6.0 IU) or BZ043 plus GLAR low dose (1.5 IU) in separate injections, and had free access to 5% glucose rich chow and water. BZ043 dose-proportionally prevented the meal-related increase of glycemia, and the co-treatment (64 or 128 nmol/kg) with GLAR restored normoglycemia without abrupt variations of glycemia. BZ043 showed a prolonged anti-hyperglycemic effect and, together with GLAR, promoted a long-lasting normoglycemia, in vivo. We conceive that combining BZ043 and GLAR in a fixed-ratio co-formulation might conveniently improve the control of diabetes mellitus.
 
Access the full paper co-authored by our patent specialist Caio França by clicking here.
Back

Last related news

May 14, 2024

Partner Flávia Tremura co-authored MARQUES guide for 2024 sports events

Our partner Flávia T. Polli Rodrigues was one of the authors of the guide “Ambush Marketing and Advertising Risks for Brands: Best Practices Partner Flávia Tremura co-authored MARQUES guide for 2024 sports events

Ler notícia

April 25, 2024

The second edition of the Advertising Law: Annual Retrospective is now available

Kasznar Leonardos’ Marketing & Entertainment Law practice group is pleased to publish its second Advertising Law Year in Review newsletter, highlighting the The second edition of the Advertising Law: Annual Retrospective is now available

Ler notícia

March 18, 2024

Kasznar Leonardos contributes to the “Brazil: Life Sciences” guide by The Legal 500

Kasznar Leonardos is proud to be a contributor to the Legal 500’s “Brazil: Life Sciences” guide. Our partners Priscila Kashiwabara and Viviane Kasznar Leonardos contributes to the “Brazil: Life Sciences” guide by The Legal 500

Ler notícia
plugins premium WordPress